# Clinical Assessment of Pidogrel® Versus Plavix® (CAPP)

> **NCT01431495** · PHASE4 · COMPLETED · sponsor: **Les Laboratoires des Médicaments Stériles** · enrollment: 219 (actual)

## Conditions studied

- Coronary Disease

## Interventions

- **DRUG:** Pidogrel
- **DRUG:** Plavix

## Key facts

- **NCT ID:** NCT01431495
- **Lead sponsor:** Les Laboratoires des Médicaments Stériles
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-06
- **Final completion:** 2011-07
- **Target enrollment:** 219 (ACTUAL)
- **Last updated:** 2011-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01431495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01431495, "Clinical Assessment of Pidogrel® Versus Plavix® (CAPP)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01431495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*